It was reported that gastric cancer cell invasion could be induced via activation of the RhoA/ROCK pathway by IL-6 [23], and RhoA and RhoC siRNA gene therapy mediated by adenovirus has been suggested as useful for inhibiting the growth and invasion of human gastric carcinoma via the PI3K/Akt pathway [24]. Here, RHOA is linked to gastric carcinoma.